CHP
AGN

Castle Hook Partners’s Allergan plc AGN Stock Holding History

Castle Hook Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-123,740
Closed -$25.4M – 87
2017
Q3 		$25.4M Sell
123,740
-65,948
-35% -$15.3M 0.82% 20
2017
Q2 		$46.1M Buy
+189,688
New +$44.6M 3.02% 3

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Castle Hook Partners's AGN Position: Q4 2017 in Review

Castle Hook Partners sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 123,740 shares — an estimated $25.4M sold.

Castle Hook Partners first reported a position in AGN in Q2 2017 and held it in 2 quarters. The position peaked at $46.1M in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Castle Hook Partners reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Castle Hook Partners sold 123,740 Allergan plc shares in Q4 2017, an estimated $25.4M.
  • Castle Hook Partners first reported a position in Allergan plc in Q2 2017 and held it in 2 quarters.
  • Castle Hook Partners's Allergan plc position peaked at $46.1M in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Castle Hook Partners's 13F filing for Q4 2017, filed 14 Feb 2018.